Conmed (CNMD) Tops Q1 EPS by 3c
Get Alerts CNMD Hot Sheet
Price: $70.01 --0%
Revenue Growth %: +5.7%
Financial Fact:
Weighted average common shares Basic: 27.82M
Today's EPS Names:
UXIN, TOWN, NRIM, More
Revenue Growth %: +5.7%
Financial Fact:
Weighted average common shares Basic: 27.82M
Today's EPS Names:
UXIN, TOWN, NRIM, More
Join SI Premium – FREE
Conmed (NASDAQ: CNMD) reported Q1 EPS of $0.38, $0.03 better than the analyst estimate of $0.35. Revenue for the quarter came in at $186.6 million versus the consensus estimate of $181.38 million.
- Sales of $186.6 million increased 3.0% as reported compared to the first quarter of 2016. On a constant currency basis, sales increased 3.7%.
- International revenue grew 2.4% as reported and 3.9% in constant currency, driven by continued growth in General Surgery and Orthopedics.
- Domestic General Surgery sales grew 9.5%, contributing to 3.5% overall domestic revenue growth.
- Diluted net loss per share (GAAP) was $0.16, compared to diluted net loss per share (GAAP) of $0.08 in the first quarter of 2016.
- Adjusted diluted net earnings per share(1) were $0.38 versus $0.42 in the prior-year period.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Conmed (CNMD) Tops Q1 EPS by 5c, provides guidance
- SLM (SLM) Tops Q1 EPS by 20c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!